Status:

RECRUITING

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

Lead Sponsor:

European Institute of Oncology

Collaborating Sponsors:

Associazione Italiana per la Ricerca sul Cancro

Conditions:

Lung Neoplasm Malignant

Eligibility:

All Genders

18+ years

Brief Summary

Stereotactic Body Radiotherapy (SBRT) is a form of high-precision radiotherapy playing a major role in patients diagnosed with early-stage non-small cell lung cancer (NSLCL), especially when surgery c...

Detailed Description

The overall planned duration of the study is 60 months. The project is structured into five main tasks, as following: * Task 1\_Clinical study: Routine clinical data will be collected from eligible ...

Eligibility Criteria

Inclusion

  • Histologically proven NSCLC; all histologies will be considered eligible (e.g. squamous, adenocarcinoma, large cell carcinoma);
  • American Joint Committee on Cancer Tumor Node Metastasis (AJCC TNM) classification (8th Edition) clinical stage I-II;
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-1;
  • No absolute contraindications to either surgery (e.g. severe comorbidities) or SBRT (e.g. active connective diseases, severe pulmonary fibrosis);
  • Ability and willingness to sign a written informed consent for treatment and study participation.

Exclusion

  • Prior diagnosis of invasive cancer (within 3 years before the diagnosis of ES-NSCLC);
  • Mental diseases or psychiatric disorders preventing the acquisition of a valid informed consent.

Key Trial Info

Start Date :

September 11 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2028

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT05974475

Start Date

September 11 2023

End Date

September 1 2028

Last Update

September 23 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Istituto Europeo di Oncologia IRCCS

Milan, Italy, Italy, 20141

2

Istituto Europeo di Oncologia (IEO) IRCCS

Milan, Lombardy, Italy, 20141

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | DecenTrialz